advertisement
Ahmed I 9
Showing records 1 to 9 | Display all abstracts from Ahmed I80283 Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT
Inamoto Y
Bone marrow transplantation 2019; 54: 648-661
81077 Disease-specific Preference-based Measure of Glaucoma Health States: HUG-5 Psychometric Validation
Kennedy K
Journal of Glaucoma 2019; 28: 593-600
80283 Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT
Petriček I
Bone marrow transplantation 2019; 54: 648-661
81077 Disease-specific Preference-based Measure of Glaucoma Health States: HUG-5 Psychometric Validation
Podbielski D; Nanji K
Journal of Glaucoma 2019; 28: 593-600
80283 Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT
Burns L; Chhabra S
Bone marrow transplantation 2019; 54: 648-661
81077 Disease-specific Preference-based Measure of Glaucoma Health States: HUG-5 Psychometric Validation
Muratov S; Ahmed I
Journal of Glaucoma 2019; 28: 593-600
80283 Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT
DeFilipp Z; Hematti P
Bone marrow transplantation 2019; 54: 648-661
81077 Disease-specific Preference-based Measure of Glaucoma Health States: HUG-5 Psychometric Validation
Xie F
Journal of Glaucoma 2019; 28: 593-600
80283 Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT
Rovó A; Schears R; Shah A; Agrawal V; Al-Khinji A; Ahmed I; Ali A; Aljurf M; Alkhateeb H; Beitinjaneh A; Bhatt N; Buchbinder D; Byrne M; Callander N; Fahnehjelm K; Farhadfar N
Bone marrow transplantation 2019; 54: 648-661
